Overview

Clinical Study of Neoadjuvant Chemotherapy and Immunotherapy Combined With Probiotics in Patients With Potential/Resectable NSCLC

Status:
Recruiting
Trial end date:
2027-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and effect of neoadjuvant chemotherapy and immunotherapy combined with probiotics for early resectable NSCLC patients.
Phase:
Phase 1
Details
Lead Sponsor:
Xiangya Hospital of Central South University
Treatments:
Carboplatin
Nivolumab
Paclitaxel